Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Roche’s Herceptin Heart Risk Higher for Older Women, Study Says

Don't Miss Out —
Follow us on:

Aug. 10 (Bloomberg) -- Roche Holding AG’s cancer drug Herceptin poses a bigger risk of heart problems for elderly patients than for the younger women usually recruited in clinical trials, researchers said in a study published today in the journal Annals of Oncology.

The study reviewed records for 45 women between the ages of 70 and 92, and it’s the first to assess the Roche drug’s heart risks specifically for elderly patients, researchers said.

To contact the reporter on this story: Naomi Kresge in Zurich at nkresge@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.